SUMMARY Few data from randomised prospective studies address whether early diet influences later neurodevelopment in man. As part of a larger multicentre trial, 502 low birthweight infants were assigned randomly, for a median of 30 days, to receive a preterm formula or unfortified donor breast milk as sole diets or as supplements to their mothers' expressed milk. Surviving infants were assessed at nine months after their expected date of delivery without knowledge of their feeding regimen. The mean developmental quotient was 0*25 standard deviations lower in those fed donor breast milk rather than preterm formula. In infants fed their mother's expressed milk, however, the disadvantage of receiving banked milk compared with preterm formula as a supplement, was greater when the supplement was over half the total intake, and approached five points, representing 0O5 standard deviations for developmental quotient. Infants fed donor breast milk were at particular disadvantage following fetal growth retardation, with developmental quotients 5.3 points lower.
Whether early diet influences later development is a key question in infant nutrition that has stimulated numerous investigations in animals and man. Most animal studies have been in rats, whose young are very immature at birth. In such experiments both prenatal and early postnatal malnutrition may have significant neurological consequences including a serious loss of brain cells found at necropsy,l a brain-weight deficit that usually remains after nutritional rehabilitation,=5 and impaired performance in learning tasks and visual discrimination tests .6 In human infants who have died of severe malnutrition, the total number of brains cells has been found to be reduced by 15-20% , and by 60% in those born weighing under 2000 g,7 which suggests that all low birthweight infants (whether or not they are small for gestational age) are especially vulnerable to poor postnatal nutrition. Human studies on early diet and later neurodevelopment, however, are difficult to interpret. Much work in humans concerns the consequences of malnutrition in developing countries, where poor diet is associated with medical and social problems that confound any analysis. Thus some workers report behavioural or intellectual benefits from dietary supplementaion following malnutrition in infancy,8 9 whereas others suggest that stimulation was essential for these benefits.") Evidence indicating that early nutrition may have lasting neurodevelopmental effects has, however, come from many other sources. These include studies on malnutrition associated with disease (for instance, infantile hypertrophic pyloric stenosis, which has been associated with later deficits in attention and memory") and with the effects of specific nutrient deficiencies (for example, iron'2).
Nevertheless it has been difficult to conduct controlled randomised trials to test the hypothesis that early diet is critical for later neurodevelopment in humans. We considered that the preterm infant, born during a phase of rapid brain growth, would be an important model for such a study; currently used 1570 Early diet in preterm babies and developmental status in infancy 1571 diets differ greatly in composition and randomised dietary assignment is practical. Furthermore a conclusive outcome trial would have important implications for clinical management.
We have therefore conducted a prospective, randomised five centre trial of the effect of diet on long term neurodevelopment in infants weighing under 1850 g at birth. The cohort will be followed into adult life; the first formal follow up was 18 months after their expected date of delivery, but in three East Anglian centres we also examined surviving infants at nine months after their expected date of delivery. Our findings at nine months are reported here.
Patients and methods
All infants weighing less than 1850 g admitted to the neonatal units in Cambridge, Ipswich, or King's Lynn over the three year period 1982-4 were entered into this study. Babies were excluded only if they had a major congenital abnormality known to impair growth or development (for example, trisomy), or if they died before randomisation (within the first 48 hours). Approval was obtained for the study from the local ethics committee in each of the trial centres. An important aspect of this study is that after detailed explanation of the study to the guardian(s), consent for the infant to take part was never withheld, so that there was no selection bias in the cohort.
Each mother was asked whether or not she wished to provide expressed breast milk for her infant. If a mother chose not to provide her milk, the infant was randomly allocated either banked donor breast milk or preterm formula as the sole diet (trial 1). Infants whose mothers elected to provide breast milk were randomly allocated (trial 2) either banked donor breast milk or preterm formula as a supplement to be used when mothers were unable to provide sufficient milk to meet their infants' enteral feed volume requirements. The median intake of maternal milk in this 'supplement trial' was 53% of the infants' feed volume during the study. Randomisation, by permuted blocks of variable length, was stratified by centre and birth weight; infants whose birth weight was below 1200 g were randomised separately. Full details of the randomisation, feeding regimens, and preterm formula composition have been published elsewhere,'13 but briefly, the preterm formula contained 2 g protein, 0-335 MJ (80 kcal), 35 mg phosphorus, 70 mg calcium, and 45 mg sodium 100 ml. Before the start of the study in 1982 all infants in the three centres were fed on human milk (banked, or mothers' own, or a combination).
Extensive data were collected on obstetric, fetal, Table 3 shows mean developmental scores for all five fields of development and for overall developmental quotient in the randomised comparisons. These data do not include scores for neurologically impaired infants, which are considered separately.
When the two trials were combined the infants Table 3 Developmental scores at nine months after the expected date of delivery for infants born preterm who had been randomly assigned during the early weeks after birth to receive banked breast milk or preterm formula as: sole diets or supplements to mothers milk (trials 1 and 2 combined); as sole diets (trial 1); or as supplements to their mothers' milk (trial 2). Data include overall developmental quotient and scores forfive individual fields ofdevelopment, expressed as mean (SD) with 95% confidence intervals for benefit from preterm formula receiving preterm formula, either as sole diet or as supplement to their mothers' milk, had higher mean scores in all areas of development than those given donor milk as sole diet or supplement. Significant differences were seen in adaptive, fine motor, language, and personal-social areas, as well as in overall developmental quotient (95% confidence interval (CI) for difference: 0-4 to 4-6, p<O-02).
None of the differences seen between those infants receiving either donor breast milk or preterm formula as sole diet (the smaller of the two trials) reached significance, though there was a trend in favour of the preterm formula. In the larger group of infants whose mothers chose to provide breast milk, however, those supplemented with formula had higher mean scores in all areas of development than those supplemented with donor milk. The differences were significant in adaptive, language, and personal-social scores, also in overall developmental quotient where a three point advantage (95% CI 0-5 to 5-6, p<O-02) is seen for formula fed Fig 1 Mean developmental quotient at nine months after the expected date of delivery in preterm infants randomly assigned to receive either banked breast milk or preterm formula as supplements to their mothers' milk. Mean (SEM) values from babies for whom this supplement was 50% or less of intake are shown on the left, andfor those for whom it was over 50% are shown on the right. infants. In this 'supplement trial', however, mothers provided varying proportions of their infants' milk volume requirements. When mothers provided most of the infants' feed volume, the nature of the randomly assigned supplement could not be expected to make a major difference to outcome. Thus any difference in outcome between donor milk and preterm formula given as supplements to maternal milk would be blunted. We planned in advance therefore to analyse the results separately for infants of mothers providing up to half of the enteral intake and those whose mothers provided more than half. As expected, developmental advantages for infants given preterm formula rather than banked milk were greater for those infants where the supplement comprised more than half of their milk volume requirement, with a 4 9 point advantage in developmental quotient for those receiving the formula rather than donor milk (101-4 (SD 10-5) compared with 96*5 (9.9), p<001) (fig 1 and  table 4 ).
Infants with neurological impairments (n=31) were considered separately. For those fed donor milk compared with formula as sole diets or supplement the mean (SE) developmental quotients were 74-4 (4.0) and 79-3 (4.9), respectively.
A birthweight cut off of 1200 g was used for stratifying the randomisation, after we had established from local statistics that this figure was the watershed for prognosis. The developmental advantage for infants fed preterm formula, however, was equal above or below this value.
SUBGROUP ANALYSES
To investigate whether associations between diet and development were more evident in some subgroups, further analyses of the data were undertaken. For these analyses both trials were combined (preterm formula compared with banked milk as sole diets or supplements to mothers' milk). Subgroups investigated were: infants whose birth weights were appropriate for gestational age compared with those who were small for gestational age (less than the 10th centile), girls compared with boys, and those ventilated for less than 24 hours compared with those ventilated for 24 hours or longer.
The results are shown in fig 2 and Interestingly, infants receiving donor milk showed significant disadvantages in all fields of development except language after fetal growth retardation (table  5) , whereas in infants of appropriate birth weight for gestational age the only significant disadvantage (not depicted) was seen on the language subscale (donor milk: 93-9 (11-0) compared with preterm formula: 97-8 (13-4)) (p<002). In this field there was also some evidence of interaction between diet and whether or not the infant's growth was retarded (p=O0O9).
Boys compared with girls Boys given preterm formula had a 3-3 point advantage in development quotient (95% CI 0 4 to 6-1), whereas girls had a smaller 1-7 point advantage (95% CI 1-6 to 4.7) (fig 2(b) ). A significant interaction between the dietary effects and sex of the infant was not found, however.
Neonatal ventilation
In infants ventilated for less than 24 hours there was no significant association between diet and developmental quotient, whereas those infants ventilated for 24 hours or more had a mean quotient which was 3.7 points higher if they received the formula rather than donor milk (95% CI 0-1 to 7.4) (fig 2(c) ), with a 6-2 point advantage in language development (95% CI 2-4 to 10 0, p<OO002). In language development there was a significant interaction (p<0-01) between the diet and whether the baby required mechanical ventilation for 24 hours or more.
Discussion
We have tested whether early diet influences neurodevelopment in man in a large, randomised, prospective trial of feeding in preterm infants. We found that the diet assigned during the early weeks after birth had a significant effect on developmental status nine months after the expected date of delivery. Infants fed a special cows' milk based preterm formula, had a significantly higher overall developmental quotient (when assessed by someone who was unaware of the randomisation) than those fed banked donor breast milk, when these diets were used alone and in combination with mothers' expressed milk. Though preterm formula feeding was associated with particular advantages in certain fields of development and subgroups of infants, in no specific instance was there any advantage for donor breast milk. These data have important biological implications and are pertinent to the long standing debate on whether unfortified mature human milk meets the nutritional requirements of premature babies.13
The developmental screening inventory of Knobloch et al that was used in this study consists of selected items from the Gesell developmental schedules.16 When Gesell developmental quotient and Stanford-Binet intelligence quotient at school age are compared, the Pearson correlation coefficient (r) is 0 70, rising to 0-84 after weighting for socioeconomic state and incidence of convulsive seizures. '6 We expect that the correlation between mean development quotient and later mean intelligence quotient in randomised groups may be even better than correlations based on individuals. The longer term significance of our findings, however, is to be assessed at future follow up throughout childhood and beyond.
In trial 1, banked milk and preterm formula were assigned randomly as sole diets; in trial 2, they were given as supplements to the mothers' expressed breast milk (in volumes according to maternal success in providing sufficient milk to meet the infants' total feed volume requirement). Because in both trials the dietary assignment was random, demographic and clinical factors other than diet were equally represented between the two groups. Moreover, the combination of trials 1 and 2 was a balanced addition so that banked milk (as sole diet or supplement) compared with preterm formula (as sole diet or supplement) was still a randomised comparison.
We suggest that the observed significant differences in developmental scores between randomised diet groups are biologically important. Unlike intelligence quotient, the overall standard deviation for developmental quotient at nine months was only 10 points. In the whole cohort the overall disadvantage in developmental quotient on donor milk was 0-25 SD and in several major subgroups (see below) this disadvantage was 5 to 8 points (>0.5 SD).
Although other factors (such as very low gestational age or severe respiratory disease) are associated with larger differences in developmental status at this age, diet is one of the few potential influences on development that can be manipulated in clinical practice.
Given that donor breast milk conferred a later developmental disadvantage overall, it was surprising that no significant differences were found in the comparison of banked donor breast milk or preterm formula as sole diets (trial 1). This was the smaller of the two trials, however, and the trend was generally towards a reduced developmental quotient on donor milk. The randomised comparison between donor milk and preterm formula as supplement to mother's milk, based on a much larger sample, showed a significant developmental disadvantage for the infants fed on donor breast milk. In infants whose mothers provided their own milk, the developmental disadvantage for those receiving donor milk rather than preterm formula as a supplement was greater when the intake of supplement was more than half the feed volume requirements. This 'dose response' association further supports the evidence for an early dietary effect on development.
In addition to effects of diet on overall developmental quotient, the randomised groups (trials 1 plus 2) differed significantly in performance on four of the five individual subscales (adaptive, fine motor, language, and personal-social skills) but not in gross motor skills. The standard deviation on the gross motor score, however, was large (table 3), suggesting that preterm infants are selectively damaged in this respect, and a large population would have been required to detect a diet related difference in this subscale. Nevertheless, gross motor scores were significantly influenced by diet in infants born with retarded growth.
Prenatal and neonatal malnutrition have each been shown to be associated with a 15% reduction in the total number of brain cells in rats; yet when 'doubly deprived', with both prenatal and postnatal malnutrition, they suffered a 60% reduction in the total number of brain cells by the time of weaning. '7 Though such data have uncertain relevance to man, we speculate that the infants in this study who were small for gestational age could be regarded as doubly deprived if, after intrauterine growth retardation, they were then fed an 'unfortified' diet such as banked breast milk (as a sole diet or supplement to maternal milk). Our previous studies'3 have indicated that human milk did not support intrauterine rates of somatic or head growth during the neonatal period, even in infants of normal birth weight, and certainly did not provide adequate nutrition for catch up growth in most of the infants born *after growth had been retarded.
The significant interaction between diet and fetal growth retardation for developmental outcome indicates that infants in whom growth is retarded are especially vulnerable to postnatal undernutrition. Preterm formula fed infants had similar developmental quotients whether they were small or of appropriate size for gestational age, whereas infants fed donor milk were at a significant disadvantage if they were in the small for gestational age subgroup (fig 2(a) ). Thus Our multicentre study should be viewed as a group of 'management trials'. They were designed to answer the question: does the diet chosen for a preterm infant in the neonatal unit influence long term outcome? No attempt has been made to influence dietary management in the time period between discharge from the neonatal unit and the follow up examination. As the groups were assigned randomly, differences in feeding practice in this intervening period should not have occurred unless part of the effect of the initial diet was to induce some persistent change influencing the way the baby was subsequently fed.
Viewed solely as a management trial our study should not be expected to provide an explanation for any benefit in outcome that emerged. We have included a number of physiological and behavioural studies within these trials and our future analyses may shed light on the mechanisms responsible for observed outcomes The effects of early diet on later development shown in these infants have important implications for the dietary management of low birthweight infants, and bear on the more general issue of whether early diet has persistent neurodevelopmental consequences in man. Clearly future planned follow up of this cohort will permit us to examine the significance of our observations in terms of later performance.
developmental status in infancy.
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